These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24261150)

  • 1. Stability of midazolam in syrspend SF and syrspend SF cherry.
    Geiger CM; Sorenson B; Whaley PA
    Int J Pharm Compd; 2013; 17(4):344-6. PubMed ID: 24261150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of captopril in SyrSpend SF.
    Geiger CM; Sorenson B; Whaley PA
    Int J Pharm Compd; 2013; 17(4):336-8. PubMed ID: 24261148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of rifampin in SyrSpend SF.
    Sorenson B; Whaley P
    Int J Pharm Compd; 2013; 17(2):162-4. PubMed ID: 23696177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of vancomycin in SyrSpend SF.
    Whaley PA; Voudrie MA
    Int J Pharm Compd; 2012; 16(2):167-9. PubMed ID: 23050329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of ursodiol in SyrSpend SF Cherry flavored.
    Geiger CM; Voudrie MA; Sorenson B
    Int J Pharm Compd; 2012; 16(6):510-2. PubMed ID: 23259368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of omeprazole in SyrSpend SF Alka (reconstituted).
    Whaley PA; Voudrie MA; Sorenson B
    Int J Pharm Compd; 2012; 16(2):164-6. PubMed ID: 23050328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of gabapentin in SyrSpend SF.
    Sorenson B; Voudrie MA; Gehrig D
    Int J Pharm Compd; 2012; 16(4):347-9. PubMed ID: 23050395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution).
    Voudrie Ii MA; Allen DB
    Int J Pharm Compd; 2010; 14(1):82-6. PubMed ID: 23965375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of propranolol hydrochloride in SyrSpend SF.
    Geiger CM; Voudrie MA; Sorenson B
    Int J Pharm Compd; 2012; 16(6):513-5. PubMed ID: 23259369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF.
    Geiger CM; Sorenson B; Whaley P
    Int J Pharm Compd; 2015; 19(5):420-7. PubMed ID: 26775449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of cholecalciferol, haloperidol, imipramine hydrochloride, levodopa/carbidopa, lorazepam, minocycline hydrochloride, tacrolimus monohydrate, terbinafine, tramadol hydrochloride and valsartan in SyrSpend SF PH4 oral suspensions.
    Polonini HC; Silva SL; Cunha CN; Brandão MA; Ferreira AO
    Pharmazie; 2016 Apr; 71(4):185-91. PubMed ID: 27209697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions.
    Kabiche D; Balde IB; Majoul E; Kabiche S; Bourguignon E; Fontan JE; Cisternino S; Schlatter J
    Int J Pharm Compd; 2017; 21(2):160-163. PubMed ID: 28346212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions.
    Polonini HC; Loures S; de Araujo EP; Brandão MA; Ferreira AO
    Int J Pharm Compd; 2016; 20(5):426-434. PubMed ID: 28339378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of extemporaneously prepared rufinamide oral suspensions.
    Hutchinson DJ; Liou Y; Best R; Zhao F
    Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4.
    Ferreira AO; Polonini H; da Silva SL; Aglio NCB; Abreu J; Fernandes BMA
    Int J Pharm Compd; 2017; 21(4):339-346. PubMed ID: 28719377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of midazolam hydrochloride in extemporaneously prepared flavored gelatin.
    Bhatt-Mehta V; Johnson CE; Kostoff L; Rosen DA
    Am J Hosp Pharm; 1993 Mar; 50(3):472-5. PubMed ID: 8442465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of reconstituted fluconazole oral suspension in plastic bottles and oral syringes.
    Dentinger PJ; Swenson CF
    Ann Pharmacother; 2009 Mar; 43(3):485-9. PubMed ID: 19208778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4.
    Polonini H; da Silva SL; Cunha CN; Ferreira AO; Anagnostou K; Dijkers E
    Int J Pharm Compd; 2020; 24(3):252-262. PubMed ID: 32401746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of midazolam hydrochloride in a flavored, dye-free oral solution.
    Steedman SL; Koonce JR; Wynn JE; Brahen NH
    Am J Hosp Pharm; 1992 Mar; 49(3):615-8. PubMed ID: 1598938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of extemporaneously prepared cinacalcet oral suspensions.
    Thomson K; Hutchinson DJ; Chablani L
    Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.